Matthew W. Nelson, PharmD, BCPP
- 3Articles
- 4.5KReads1
- 2004–2007Active
- 6Collaborators
About
Matthew W. Nelson, PharmD, BCPP, has published on topics including cardiology, dementia, neurology, and schizophrenia/schizoaffective disorders. His work in Psychiatrist.com has focused on the effects of galantamine, particularly its impact on QTc prolongation and its therapeutic role in apathy among schizophrenia patients. Nelson has collaborated with authors such as Robert W. Buchanan and David S. Arnold.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
